Search
-
Progress and Polarisation: Global Attitudes Toward Gender Equality in 2025
Ipsos' International Women's Day Survey Reveals Mixed Views on Gender Equality Advancements and Societal Tensions.
-
With the acquisition of Ipec, Ipsos strengthens its Public Affairs business and reinforces its position in Brazil
Acquisition announcement from Ipsos.
-
Good profitability and cash flow generation despite slower growth in 2024
Ipsos announces its 2024 Annual Results.
-
CX Signals GenAI: Unlock deeper CX insights by leveraging unfiltered customer sentiment on social media and reviews
Harness the power of social media and reviews to help improve your Customer Experience (CX).
-
Ipsos Webinar | Luxury Ambassadors and Influencers: shaping the face of your brand
Join us to get and exclusive look into insights from our large expertise with the Luxury sector. If you want to understand how to improve your strategy, Ipsos and Trendstop will provide you actionable direction for you to implement successful brand and creative strategies
-
European Observatory of Rare Diseases reveals that Europeans find conditions for patients with rare diseases are unacceptable
ASAP FOR CHILDREN has published the results of its third European Rare Disease Observatory conducted by Ipsos.
-
Aligning Your ESG Strategy with Consumer Expectations for Your Category
Companies are increasingly investing in ESG (Environmental, Social, and Governance) initiatives to meet regulations, trends, and consumer expectations. Understanding these expectations is crucial for aligning ESG strategies with consumer values and achieving brand success.
-
The Women’s Forum for the Economy & Society unveils its 2024 Barometer, in partnership with Ipsos
On the occasion of the 19th edition of its Global Meeting, the Women’s Forum reveals the results of its annual barometer on gender inequalities, developed in partnership with Ipsos, among a sample of 3,500 people residing within the countries of the G7.
-
GLP–1s: A Healthcare Revolution?
One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.